FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

MR Contour DL Model Cleared for Organ Segmentation

[ Price : $8.95]

FDA clears a GE HealthCare 510(k) for its MR Contour DL, an artificial intelligence model that uses deep learning for organs-at-ri...

Agency Accepts Oral Wegovy NDA for Obesity

[ Price : $8.95]

FDA acccepts for review a Novo Nordisk NDA for a once-daily, 25 mg oral formulation of Wegovy (semaglutide) for chronic weight man...

FDA Rehiring Freedom of Information Staff

[ Price : $8.95]

FDA rehires some Freedom of Information office workers who were terminated under White House-mandated reduction-in-force cuts.

Vanda Tradipitant Scheduling Order Out

[ Price : $8.95]

The FDA Office of Scientific Integrity publishes a scheduling order for Vandas request for a hearing on a proposed CDER order to d...

FDA Rehiring Some Travel Support Staff

[ Price : $8.95]

The Associated Press reports FDA is attempting to rehire some travel support, food scientist, and Freedom of Information Act staff...

FDA Approves Element Science Wearable Defibrillator

[ Price : $8.95]

FDA approves the Element Science PMA for its Jewel Patch wearable cardioverter defibrillator.

Edwards Expands SAPIEN for Asymptomatic Patients

[ Price : $8.95]

FDA approves Edwards Lifesciences' SAPIEN 3 transcatheter aortic valve replacement platform for patients with severe aortic stenos...

Semaglutide Wins in Steatohepatitis, Fibrosis

[ Price : $8.95]

A Phase 3 trial funded by Novo Nordisk showed that its Ozempic/Wegovy outperformed placebo in patients with steatohepatitis and fi...

Drug Safety Monitoring Hurt by FDA Staff Cuts: Post

[ Price : $8.95]

Chemistry & Engineering News reports that reductions in CDER Division of Drug Information staff are affecting FDAs ability to main...

Placebo-controlled Trials Needed for Vaccines: HHS

[ Price : $8.95]

A self-described radical HHS policy now requires all new vaccines to be evaluated in placebo-controlled trials before theyre licen...